{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:17:37Z","timestamp":1790007457614,"version":"4.0.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2020726"],"award-info":[{"award-number":["BE2020726"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the efficacy and safety of ultrasound-guided microwave ablation (MWA) in the treatment of primary hyperparathyroidism (PHPT), and to investigate whether MWA can improve the bone turnover and renal function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 20 consecutive PHPT patients with 21 parathyroid lesions treated with MWA in our center from May 2019 to March 2021 were recruited in this study. Serum parathyroid hormone (PTH), calcium and phosphorus levels before MWA and at 20 minutes, 4 hours, 1 day, 3 months, 6 months and 12 months after MWA were measured. Bone turnover biomarkers, renal function and lesion volume with volume reduction rate (VRR) before MWA and at the last follow-up were compared. Any complication related with MWA was evaluated. The technical and clinical success rates of MWA in the treatment of PHPT were calculated. Clinical success was defined as normal serum PTH and calcium without PHPT-associated manifestations at more than 6 months after ablation. Technical success was defined as complete ablation indicated by immediate postoperative contrast-enhanced ultrasound.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The serum PTH, calcium and phosphorus levels at their respective follow-up time points dropped significantly after MWA (<jats:italic>P &amp;lt;<\/jats:italic>0.05). The volume of parathyroid lesions at the final examination was significantly reduced, compared with pre-ablation volume (<jats:italic>P &amp;lt;<\/jats:italic>0.001), with a median VRR reaching 89%. The technical and clinical success rates were 100% and 63.6%, respectively. Substantial changes of bone turnover biomarkers were observed before and after MWA (<jats:italic>P &amp;lt;<\/jats:italic>0.05), but the differences in renal function were not statistically significant. No major complications were reported in all cases. Pre-MWA serum PTH, lesion volume, maximum diameter of lesion and ablation time were significantly different between patients with successful and failed MWA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PHPT can be effectively and safely treated by ultrasound-guided MWA, as proven by drop in serum PTH and reduction in the volume of parathyroid adenomas. Besides, MWA can impede bone remodeling to suppress hyperparathyroidism in the condition of PHPT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.782050","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:33:43Z","timestamp":1638405223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism"],"prefix":"10.3389","volume":"12","author":[{"given":"Wenjing","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30188-3","article-title":"Three Generational Phenotypes of Sporadic Primary Hyperparathyroidism: Evolution Defined by Technology","volume":"7","author":"Cipriani","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular Trends in the Incidence of Primary Hyperparathyroidism Over Five Decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2914","article-title":"The Changing Clinical Patterns of Primary Hyperparathyroidism in Chinese Patients: Data From 2000 to 2010 in a Single Clinical Center","volume":"98","author":"Zhao","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2019.1645365","article-title":"Comparison of Ultrasound-Guided Percutaneous Microwave Ablation and Parathyroidectomy for Primary Hyperparathyroidism","volume":"36","author":"Yu","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary Hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of Kidney Stones and Vertebral Fractures in Primary Hyperparathyroidism Using Imaging Technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/07435800.2018.1431275","article-title":"Occult Urolithiasis in Asymptomatic Primary Hyperparathyroidism","volume":"43","author":"Tay","year":"2018","journal-title":"Endocr Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05822-9","article-title":"Risk of Fractures in Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis","volume":"32","author":"Ejlsmark-Svensson","year":"2021","journal-title":"Osteoporos Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345404","article-title":"High-Intensity Focused Ultrasound as an Alternative to the Surgical Approach in Primary Hyperparathyroidism A Preliminary Experience","volume":"34","author":"Ambrosini","year":"2011","journal-title":"J\u00a0Endocrinol Invest."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.8442","article-title":"Long-Term Effectiveness of Ultrasound-Guided Laser Ablation of Hyperfunctioning Parathyroid Adenomas: Present and Future Perspectives","volume":"199","author":"Andrioli","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-014-3252-4","article-title":"US-Guided High-Intensity Focused Ultrasound as a Promising non-Invasive Method for Treatment of Primary Hyperparathyroidism","volume":"24","author":"Kovatcheva","year":"2014","journal-title":"Eur Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"673604","DOI":"10.1155\/2015\/673604","article-title":"Percutaneous Ultrasound-Guided Laser Ablation With Contrast-Enhanced Ultrasonography for Hyperfunctioning Parathyroid Adenoma: A Preliminary Case Series","volume":"2015","author":"Jiang","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2016.02.013","article-title":"US-Guided Percutaneous Microwave Ablation for Primary Hyperparathyroidism With Parathyroid Nodules: Feasibility and Safety Study","volume":"27","author":"Wu","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2018.1453552","article-title":"Feasibility of Bipolar Radiofrequency Ablation in Patients With Parathyroid Adenoma: A First Evaluation","volume":"34","author":"Korkusuz","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06078-y","article-title":"US-Guided Microwave Ablation for Primary Hyperparathyroidism: A Safety and Efficacy Study","volume":"29","author":"Fan","year":"2019","journal-title":"Eur Radiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02511-1","article-title":"Two-Year Changes of Biochemical Profiles and Bone Mineral Density After Percutaneous Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism","volume":"71","author":"Wu","year":"2021","journal-title":"Endocrine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2020.1750712","article-title":"US-Guided Laser Treatment of Parathyroid Adenomas","volume":"37","author":"Appelbaum","year":"2020","journal-title":"Int J Hyperthermia"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2020.0037","article-title":"Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics","volume":"21","author":"Ha","year":"2020","journal-title":"Korean J Radiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2019.0593","article-title":"Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism","volume":"21","author":"Wei","year":"2020","journal-title":"Korean J Radiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab240","article-title":"Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study","volume":"106","author":"Wei","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e14580","DOI":"10.1111\/ijcp.14580","article-title":"Microwave Ablation as an Efficient Therapy for Primary Hyperparathyroidism: Efficacy and Predictors of Treatment Success","volume":"75","author":"Erturk","year":"2021","journal-title":"Int J Clin Pract"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2019.1699965","article-title":"Complications Encountered in the Treatment of Primary and Secondary Hyperparathyroidism With Microwave Ablation - a Retrospective Study","volume":"36","author":"Wei","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01473-5","article-title":"Safety and Efficacy of Common Vitamin D Supplementation in Primary Hyperparathyroidism and Coexistent Vitamin D Deficiency and Insufficiency: A Systematic Review and Meta-Analysis","volume":"44","author":"Song","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-020-00574-7","article-title":"Effects of PTH and PTH Hypersecretion on Bone: A Clinical Perspective","volume":"18","author":"Rejnmark","year":"2020","journal-title":"Curr Osteoporos Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1210\/endrev\/bnab005","article-title":"Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R","volume":"42","author":"Martin","year":"2021","journal-title":"Endocr Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3390\/jcm10143089","article-title":"Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients With Primary Hyperparathyroidism","volume":"10","author":"Syka\u0142a","year":"2021","journal-title":"J Clin Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2017.0092","article-title":"Changes in Bone Turnover Markers in Primary Hyperparathyroidism and Response to Surgery","volume":"99","author":"Rajeev","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2012.11.004","article-title":"Bone Turnover Markers in Primary Hyperparathyroidism","volume":"16","author":"Costa","year":"2013","journal-title":"J Clin Densitom"},{"key":"B30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.20945\/2359-3997000000154","article-title":"Prediction of Bone Mass Changes After Successful Parathyroidectomy Using Biochemical Markers of Bone Metabolism in Primary Hyperparathyroidism: Is it Clinically Useful","volume":"63","author":"Ohe","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00923","article-title":"Predictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control Study","volume":"103","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2016.11.009","article-title":"And Unnikrishnan, Renal Dysfunction in Primary Hyperparathyroidism; Effect of Parathyroidectomy: A Retrospective Cohort Study","volume":"36","author":"Nair","year":"2016","journal-title":"Int J Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01369-4","article-title":"Parathyroidectomy Slows Renal Function Decline in Patients With Primary Hyperparathyroidism","volume":"44","author":"Liang","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0430","article-title":"MECHANISMS IN ENDOCRINOLOGY: Kidney Involvement in Patients With Primary Hyperparathyroidism: An Update on Clinical and Molecular Aspects","volume":"176","author":"Verdelli","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07761-9","article-title":"A Study on the Causes of Operative Failures After Microwave Ablation for Primary Hyperparathyroidism","volume":"31","author":"Ying","year":"2021","journal-title":"Eur Radiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2011.09.017","article-title":"Normocalcemic Parathormone Elevation After Successful Parathyroidectomy: Long-Term Analysis of Parathormone Variations Over 10 Years","volume":"150","author":"Goldfarb","year":"2011","journal-title":"Surgery"},{"key":"B37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.surg.2012.07.005","article-title":"Persistent Elevation in Serum Parathyroid Hormone Levels in Normocalcemic Patients After Parathyroidectomy: Does it Matter","volume":"152","author":"Carsello","year":"2012","journal-title":"Surgery"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00705","article-title":"Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center","volume":"104","author":"Caldwell","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6998-0","article-title":"Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism","volume":"26","author":"Sho","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20416","article-title":"A Retrospective Study of Elevated Post-Operative Parathormone in Primary Hyperparathyroid Patients>","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.782050\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:33:46Z","timestamp":1638405226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.782050\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":40,"alternative-id":["10.3389\/fendo.2021.782050"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.782050","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"article-number":"782050"}}